Axonics Bulkamid: Urinary Incontinence Treatment
Are you tired of dealing with frequent trips to the bathroom or sudden loss of urine control? If you are suffering from urinary incontinence, undergoing Bulkamid may be the solution you need. At the gynecology and urogynecology practice of Dr. Andrew Croak in Maumee, Ohio, we proudly provide the latest, state-of-the-art treatments for urinary incontinence. These treatments allow you to regain control over your life while taking care of the source of your health concerns.
Bladder leakage is common in women, with 1 in 3 suffering from stress urinary incontinence, which tends to develop as women get older, often during or after pregnancy. The leaks are caused by weakness in the pelvic floor, preventing the urethra from closing fully when sudden pressure is put on the bladder. This can allow urine to leak out during normal daily activities such as coughing, laughing, exercising or lifting an object.
Bulkamid is a soft, water-based gel delivered via a series of small injections into the urethral wall. Once it is injected, the volume of the gel adds bulk to the urethra, supporting the closing mechanism of the urethra and providing better control of urine. Similar to some facial fillers, it remains in the body over time without causing reactions in the surrounding tissue, resulting in durable, long-lasting relief.
Dr. Andrew Croak’s practice is recognized as an Bulkamid Center of Excellence which acknowledges doctors who are dedicated to delivering an extraordinary level of care, combining clinical excellence, advanced technology and patient-centered care.
LISTEN TO OUR PODCAST
BENEFITS OF
Bulkamid
Urinary Incontinence Treatment
.
- Safe & effective: In a clinical study, 92% of women reported being cured or improved.
- Simple: A series of 3 – 4 small injections that takes just 10 – 15 minutes.
- Long-lasting: Bulkamid is clinically proven to deliver symptom relief out to seven years.
- A better treatment: A majority of women with SUI chose Bulkamid before other surgical treatment options in a 2020 clinical study.